Charles Evan Ballantyne - Net Worth and Insider Trading

Charles Evan Ballantyne Net Worth

The estimated net worth of Charles Evan Ballantyne is at least $3,230 dollars as of 2024-04-24. Charles Evan Ballantyne is the CFO of Agenus Inc and owns about 500 shares of Agenus Inc (AGEN) stock worth over $3,230. Details can be seen in Charles Evan Ballantyne's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles Evan Ballantyne has not made any transactions after 2015-09-25 and currently still holds the listed stock(s).

Transaction Summary of Charles Evan Ballantyne

To

Charles Evan Ballantyne Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles Evan Ballantyne owns 3 companies in total, including Agenus Inc (AGEN) , Theriva Biologics Inc (TOVX) , and Gain Therapeutics Inc (GANX) .

Click here to see the complete history of Charles Evan Ballantyne’s form 4 insider trades.

Insider Ownership Summary of Charles Evan Ballantyne

Ticker Comapny Transaction Date Type of Owner
AGEN Agenus Inc 2015-09-25 Chief Financial Officer
TOVX Theriva Biologics Inc 2012-02-06 CHIEF FINANCIAL OFFICER
GANX Gain Therapeutics Inc 2023-04-10 Chief Financial Officer

Charles Evan Ballantyne Latest Holdings Summary

Charles Evan Ballantyne currently owns a total of 1 stock. Charles Evan Ballantyne owns 500 shares of Agenus Inc (AGEN) as of September 25, 2015, with a value of $3,230.

Latest Holdings of Charles Evan Ballantyne

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AGEN Agenus Inc 2015-09-25 500 6.46 3,230

Holding Weightings of Charles Evan Ballantyne


Charles Evan Ballantyne Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles Evan Ballantyne has made a total of 0 transactions in Agenus Inc (AGEN) over the past 5 years. The most-recent trade in Agenus Inc is the acquisition of 500 shares on September 25, 2015, which cost Charles Evan Ballantyne around $50,500.

Insider Trading History of Charles Evan Ballantyne

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles Evan Ballantyne Trading Performance

GuruFocus tracks the stock performance after each of Charles Evan Ballantyne's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Evan Ballantyne is -5.16%. GuruFocus also compares Charles Evan Ballantyne's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Evan Ballantyne within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Charles Evan Ballantyne's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Charles Evan Ballantyne

Average Return

36.9%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.2 -5.16 -22.42 36.9 -9.46 -25.17
Relative Return to S&P 500(%) -7.65 -11.87 -27.84 24.82 -23.14 -39.87

Charles Evan Ballantyne Ownership Network

Ownership Network List of Charles Evan Ballantyne

No Data

Ownership Network Relation of Charles Evan Ballantyne


Charles Evan Ballantyne Owned Company Details

What does Agenus Inc do?

Who are the key executives at Agenus Inc?

Charles Evan Ballantyne is the Chief Financial Officer of Agenus Inc. Other key executives at Agenus Inc include Chairman & CEO Garo H Armen , Chief Medical Officer Steven J O'day , and VP Finance Christine M Klaskin .

Agenus Inc (AGEN) Insider Trades Summary

Over the past 18 months, Charles Evan Ballantyne made no insider transaction in Agenus Inc (AGEN). Other recent insider transactions involving Agenus Inc (AGEN) include a net purchase of 500,000 shares made by Garo H Armen , and a net purchase of 25,000 shares made by Ulf Wiinberg .

In summary, during the past 3 months, insiders sold 0 shares of Agenus Inc (AGEN) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 0 shares of Agenus Inc (AGEN) were sold and 26,250 shares were bought by its insiders, resulting in a net purchase of 26,250 shares.

Agenus Inc (AGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Agenus Inc Insider Transactions

No Available Data

Charles Evan Ballantyne Mailing Address

Above is the net worth, insider trading, and ownership report for Charles Evan Ballantyne. You might contact Charles Evan Ballantyne via mailing address: 27 Hearthstone Road, Hopkinton Ma 01748.

Discussions on Charles Evan Ballantyne

No discussions yet.